The acquisition of drug resistance is a major hurdle for effective cancer treatment. Although
several efforts have been made to overcome drug resistance, the underlying mechanisms …

With completing the whole genome sequencing project, awareness of lncRNA further
deepened. The growth arrest-specific transcript 5 (GAS5) was initially identified in growth …

Objective To explore the core mechanism of long non-coding RNA (lncRNA) growth arrest-
specific transcript 5 (GAS5) in the regulation of multidrug resistance of pancreatic cancer …

In more recent years, long non‐coding RNAs (lncRNAs) have been investigated as a new
class of regulators of cellular processes, such as cell growth, apoptosis, and carcinogenesis …

Previous studies reported that elevated expression of long noncoding RNA (lncRNA) GAS5
led to the arrest of non-small cell lung cancer (NSCLC) cell growth and a promotion of …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer‑related mortality
worldwide. Recent studies have demonstrated that long non‑coding RNAs (lncRNAs) are …

Colorectal cancer (CRC) is the third most common cancer worldwide and its treatment
remains a challenge. Effective control of cell survival and proliferation is critical in the …

Long noncoding RNA growth-arrest-specific transcript 5 (GAS5) has been proved to play a
crucial role in cancer chemoresistance. However, the function of GAS5 and its underlying …

Aberrant expression of noncoding RNAs in glioma cells, including long noncoding RNAs
(lncRNAs) and microRNAs, may participate in the progression of glioma. Encoded by …

The long non‐coding RNA GAS 5 has been reported as a tumor suppressor in many
cancers. However, its functions and mechanisms remain largely unknown in esophageal …